Moderna to Produce Bird Flu Vaccine Under $176M BARDA Project Award

Published: Jul 02, 2024 By Tyler Patchen


Pictured: Moderna’s office in Cambridge, Massachusetts/iStock, hapabapa

Moderna announced Tuesday it has been awarded $176 million by the Rapid Response Partnership Vehicle, a consortium funded by the Biomedical Advanced Research and Development Authority, to help speed up the development of a mRNA vaccine to help fight avian flu.

The company announced that the funds are intended to assist the late-stage development and licensure of a pre-pandemic vaccine for H5N1 influenza, a highly infectious disease in birds that has been transmitted to humans. According to Moderna, the agreement will also include options to prepare and accelerate a response to future public health threats.

Moderna initiated development of a vaccine candidate, mRNA-1018, in 2023. The candidate is currently in a Phase I/II study in adults 18 years and older and is…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks